Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family
On Nov. 14, 2025, A federal bankruptcy court judge said he will approve OxyContin-maker Purdue Pharma’s latest deal…
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
Purdue Pharma $7.4 billion opioid settlement wins broad support from US states
On Jun. 16, 2025, Purdue Pharma has won support from the attorneys general of 55 U.S. states and…
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
On Mar. 19, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
U.S. Supreme Court blocks Purdue Pharma bankruptcy settlement
On Jun. 27, 2024, the U.S. Supreme Court blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have…
ViralClear added St. David’s HealthCare to phase II trial for broad-spectrum oral anti-viral COVID-19 candidate
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
Valneva and Pfizer announced a collaboration to co-develop and commercialize Lyme disease vaccine
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
Yale Science Building opened it doors
On Oct. 29, 2019, the Yale Science Building officially opened as a central hub for interdisciplinary collaboration on…
Yale professor Joan Steitz awarded the 2018 Lasker~Koshland Special Achievement Award in Medical Science
On Sept. 11, 2018, Joan Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 2018ﾠ…
Yale scientist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal
On Jan. 19, 2018, Yale evolutionary geneticist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal from the…
Connecticut United for Research Excellence (CURE) was renamed BioCT
On Jan. 12, 2018, Connecticut United for Research Excellence Inc. (CURE) renamed itself BioCT and today is the…
Rallybio was founded
In 2018, Rallybio was founded as a privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients…
Biotechnology | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress
The NIH dedicated the Lowell P Weicker building
On May 4, 2015, the National Institutes of Health (NIH) dedicated Building 4 in honor of Lowell P….
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
The Jackson Laboratory for Genomic Medicine opened its doors
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
The Connecticut Development Authority was merged into Connecticut Innovations
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
Precipio was founded
In 2011, Precipio was founded in New Haven, Connecticut to build a platform designed to eradicate the problem…
Smilow Cancer Hospital opened for patient care
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
Yale’s West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
Yale New Haven Hospital breaks ground on $838 million, 505,000 square foot Neurosciences Center
On Aug. 31, 2022, Yale New Haven Hospital (YNHH) broke ground on the $838 million, 505,000 square foot…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some cancers
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
Bristol-Myers’ Wallingford facility named the Richard L Gelb Center for Pharmaceutical R&D after former Bristol-Myers chair and CEO
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…